Literature DB >> 20459326

Single-incision laparoscopic surgery and the necessity for prospective evidence.

Carissa L Garey1, Carrie A Laituri, Daniel J Ostlie, Shawn D St Peter.   

Abstract

Laparoscopic surgery has become the standard approach for most thoracic, abdominal, and pelvic procedures in adults and children. We now know that laparoscopy has proven benefits; however, at its introduction, laparoscopy was adopted without appropriate clinical evidence to justify the approach as an alternative to open surgery. In continued efforts to increase the benefits of minimally invasive surgery to their patients, surgeons have innovated new techniques to further decrease the impact of the operation on patients. These innovations range from decreasing the size of ports and instruments to the current group of techniques termed "scarless" surgery. In the current era of evidence-based medicine, it is the surgeon's responsibility to prove that the benefits outweigh the risk before new techniques are widely applied to patients. This article seeks to review the history of laparoscopic surgery, apply lessons learned to the evolution of single-incision laparoscopic surgery, and make a statement urging for sound prospective evaluation.

Entities:  

Mesh:

Year:  2010        PMID: 20459326     DOI: 10.1089/lap.2009.0394

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  2 in total

1.  Comparison of laparoscopic skills performance between single-site access (SSA) devices and an independent-port SSA approach.

Authors:  Matthew R Schill; J Esteban Varela; Margaret M Frisella; L Michael Brunt
Journal:  Surg Endosc       Date:  2011-10-13       Impact factor: 4.584

Review 2.  Single-incision laparoscopic appendectomy vs conventional laparoscopic appendectomy: systematic review and meta-analysis.

Authors:  Yu-Long Cai; Xian-Ze Xiong; Si-Jia Wu; Yao Cheng; Jiong Lu; Jie Zhang; Yi-Xin Lin; Nan-Sheng Cheng
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.